Schedule 13G ownership disclosure
Mirati Therapeutics Inc
Security class unavailable · CUSIP: 60468T105
Event date: 2019-07-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,813,235
- Percent of class
- 9.7200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-19-003157
- Form type
- SC 13G
- Filer
- Avoro Capital Advisors LLC
- CIK
- CIK 1633313
- Filed
- Jul 25, 2019
- Reporting period
- Jul 25, 2019
- Description
- Schedule 13G beneficial ownership